trial · primary record
bi-4SCAR CD19/70 T cells
B Cell Malignancies
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Safety of fourth generation bi-4SCARCD19/70 T cells in patients with B cell malignancies |
| Registry ID | NCT05436496 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:32.596Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05436496
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.